Clinical Trial Update: Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial of bortezomib with standard chemotherapy for relapsed or refractory follicular lymphoma, which was terminated; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Duke University | Conditions: Lymphoma, Follicular | Phase 2 | Status: TERMINATED | Results posted: 2014-04-21